Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Interventional × Dermoscopy × Clear all

Phase

Status

Terminated 1 Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 1 Disease 1

Interventions

Cyclophosphamide 1253 Cisplatin 1181 Paclitaxel 1100 Radiotherapy 1086 Carboplatin 1046 Gemcitabine 1030 Docetaxel 948 Bevacizumab 871 Fluorouracil 747 Doxorubicin 671 Capecitabine 628 Dexamethasone 627 Rituximab 608 Oxaliplatin 584 Etoposide 569 pembrolizumab 545 Irinotecan 541 Filgrastim 532 Cytarabine 496 Leucovorin 487 Nivolumab 448 Vincristine 432 Prednisone 402 Bortezomib 395 Cetuximab 394 Erlotinib Hydrochloride 386 Trastuzumab 378 Methotrexate 359 Lenalidomide 354 Pemetrexed 353

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04789421 2021-03-09

NET-DAM

Azienda Ospedaliero-Universitaria di Modena

Phase NA Completed

Disease, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡